96 related articles for article (PubMed ID: 2550608)
21. Cyclic adenosine-3',5'-monophosphate-mediated cytotoxicity in steroid sensitive and resistant myeloma.
Krett NL; Zell JL; Halgren RG; Pillay S; Traynor AE; Rosen ST
Clin Cancer Res; 1997 Oct; 3(10):1781-7. PubMed ID: 9815564
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate.
Downs SM; Hunzicker-Dunn M
Dev Biol; 1995 Nov; 172(1):72-85. PubMed ID: 7589815
[TBL] [Abstract][Full Text] [Related]
23. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
24. Depolarization counteracts glucocorticoid inhibition of adenohypophysical corticotroph cells.
Lim MC; Shipston MJ; Antoni FA
Br J Pharmacol; 1998 Aug; 124(8):1735-43. PubMed ID: 9756391
[TBL] [Abstract][Full Text] [Related]
25. Novel (E)-5-(2-iodovinyl)-2'-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors.
Balzarini J; Morin KW; Knaus EE; Wiebe LI; De Clercq E
Gene Ther; 1995 Jul; 2(5):317-22. PubMed ID: 7671107
[TBL] [Abstract][Full Text] [Related]
26. The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines.
Dicitore A; Grassi ES; Caraglia M; Borghi MO; Gaudenzi G; Hofland LJ; Persani L; Vitale G
Endocrine; 2016 Jan; 51(1):101-12. PubMed ID: 25863490
[TBL] [Abstract][Full Text] [Related]
27. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
[TBL] [Abstract][Full Text] [Related]
28. 8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth.
Grassi ES; Dicitore A; Negri I; Borghi MO; Vitale G; Persani L
Endocrine; 2017 May; 56(2):388-398. PubMed ID: 27460006
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and cytotoxic activity of 6-vinyl- and 6-ethynyluridine and 8-vinyl-and 8-ethynyladenosine.
Manfredini S; Baraldi PG; Bazzanini R; Marangoni M; Simoni D; Balzarini J; De Clercq E
J Med Chem; 1995 Jan; 38(1):199-203. PubMed ID: 7837231
[TBL] [Abstract][Full Text] [Related]
30. Antagonistic action between cyclic AMP and estrogen in phosphorylation of mammary tumor nuclear proteins.
Cho-chung YS; Doud FJ
Cancer Lett; 1978 Oct; 5(4):219-24. PubMed ID: 210929
[TBL] [Abstract][Full Text] [Related]
31. [Effect of alkylating derivatives of cyclic adenosine-3' ,5'-monophosphate on proliferation of mouse bone marrow stem cells].
Stepanova SB; Koreshkova NA; Guliaev NN; Fedorov NA
Biull Eksp Biol Med; 1980 May; 89(5):590-2. PubMed ID: 6249419
[TBL] [Abstract][Full Text] [Related]
32. 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts.
Noguchi K; Murata T; Cho-Chung YS
Eur J Cancer; 1998 Jul; 34(8):1260-7. PubMed ID: 9849489
[TBL] [Abstract][Full Text] [Related]
33. Multiple mechanisms of growth inhibition by cyclic AMP derivatives in rat GH1 pituitary cells: isolation of an adenylate cyclase-deficient variant.
Martin TF; Ronning SA
J Cell Physiol; 1981 Nov; 109(2):289-97. PubMed ID: 6271795
[TBL] [Abstract][Full Text] [Related]
34. The mechanism of 8-Cl-cAMP action.
Juranić Z; Radulović S; Joksimović J; Juranić I
J Exp Clin Cancer Res; 1998 Sep; 17(3):269-75. PubMed ID: 9894761
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of two structurally related N6-substituted cAMP analogues on C6 glioma cells.
Zorn M; Maronde E; Jastorff B; Richter-Landsberg C
Eur J Cell Biol; 1993 Apr; 60(2):351-7. PubMed ID: 8392466
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.
Pinto A; Aldinucci D; Gattei V; Zagonel V; Tortora G; Budillon A; Cho-Chung YS
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8884-8. PubMed ID: 1329084
[TBL] [Abstract][Full Text] [Related]
37. A diffusible resistance factor(s) in spontaneous mitomycin resistant mammalian cancer cells.
Wan ZG; Kobayashi H; Hayakawa A; Ishigaki T
Nagoya J Med Sci; 1998 May; 61(1-2):37-45. PubMed ID: 9664765
[TBL] [Abstract][Full Text] [Related]
38. In vivo inhibition of tumor growth by cyclic adenosine 3',5'-monophosphate derivatives.
Cho-Chung YS
Cancer Res; 1974 Dec; 34(12):3492-6. PubMed ID: 4371966
[No Abstract] [Full Text] [Related]
39. Action of adenosine on cyclic 3',5'-nucleotides in glomeruli.
Abboud HE; Dousa TP
Am J Physiol; 1983 Jun; 244(6):F633-8. PubMed ID: 6305207
[TBL] [Abstract][Full Text] [Related]
40. Increased intracellular cyclic adenosine 3', 5'-monophosphate inhibits release of tumor necrosis factor-alpha from human vascular tissue and cultured smooth muscle cells.
Zhang LM; Castresana MR; Shaker IJ; Dalton ML; Leeper-Woodford SK; Newman WH
Crit Care Med; 1997 Nov; 25(11):1855-61. PubMed ID: 9366770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
